Roche launches new quantitative antibody test to measure SARS-CoV-2 antibodies, to support the evaluation of vaccines
Basel, 18 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its Elecsys ® Anti-SARS-CoV-2 S antibody test for markets accepting the CE Mark. Roche has filed for Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA). The Elecsys Anti-SARS-CoV-2 serology test can be used to quantitatively measure antibodies in people who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and can play an important part in characterising a vaccine-induced immune response.1 Specifically, the test targets antibodies which are directed against the ...
Source: Roche Media News - September 18, 2020 Category: Pharmaceuticals Source Type: news

Roche launches new quantitative antibody test to measure SARS-CoV-2 antibodies, to support the evaluation of vaccines
Basel, 18 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its Elecsys ® Anti-SARS-CoV-2 S antibody test for markets accepting the CE Mark. Roche has filed for Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA). The Elecsys Anti-SARS-CoV-2 serology test can be used to quantitatively measure antibodies in people who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and can play an important part in characterising a vaccine-induced immune response.1 Specifically, the test targets antibodies which are directed against the ...
Source: Roche Investor Update - September 18, 2020 Category: Pharmaceuticals Source Type: news

The COVID-19 Pandemic Has Erased Decades of Progress on Childhood Vaccination
While the world waits for a COVID-19 vaccine, children across the globe are going without shots already known to be life-saving. With the world in disarray due to the COVID-19 pandemic, the number of children vaccinated this year against infections like diphtheria, tetanus, pertussis, measles and pneumococcal disease has fallen to levels not seen since the 1990s, according to a new report from the Bill and Melinda Gates Foundation. “In other words,” the report reads, “we’ve been set back about 25 years in about 25 weeks.” That stark figure comes from the Gates Foundation’s annual Goalkee...
Source: TIME: Health - September 15, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news

Was I Misdiagnosed? Dr. Mallika Marshall Answers Your Coronavirus Questions
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p0").init({"mcp":"cbs","width":"100%","height":"100%","video":"4705035","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p0","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 11, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Covid-19 Boston, MA Health Healthcare Status Syndicated Local Coronavirus Coronavirus Vaccine Dr. Mallika Marshall Source Type: news

Vaccine proves effective against the most severe type of pneumonia
(Murdoch Childrens Research Institute) A pneumococcal vaccine was effective at protecting children in Laos against the most severe type of pneumonia, a new study has found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 10, 2020 Category: International Medicine & Public Health Source Type: news

Directed Enhanced Service Specification Seasonal influenza and pneumococcal polysaccharide vaccination programme 2020/21
All GP practices are expected to provide essential and those additional services they are contracted to provide to all their patients. This enhanced service specification outlines more specialised services to be provided. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 8, 2020 Category: Consumer Health News Source Type: news

Seasonal influenza DES specification – updated
The Influenza and Pneumococcal Immunisation Directed Enhanced Service specification has been amended and republished to provide for additional new cohorts of patients to be vaccinated in general practice. (Source: NHS Networks)
Source: NHS Networks - September 7, 2020 Category: UK Health Source Type: news

Updated flu DES offers little detail as GPs face 'one year at a time' updates on expanded campaign
GP practices will receive the same £10.06 fee per vaccination as last year under the 2020/21 flu and pneumococcal DES, as the government insisted plans for the 'biggest flu campaign ever' would go ahead despite a lack of detail in the updated specification. (Source: GP Online News)
Source: GP Online News - September 4, 2020 Category: Primary Care Tags: Contracts & funding Source Type: news

Johnson & Johnson Announces that Janssen ’s COVID-19 Investigational Vaccine Candidate Prevents Severe Clinical Disease in Pre-clinical Studies
Janssen’s lead SARS-CoV-2 investigational vaccine candidate, Ad26.COV2.S, prevented severe clinical disease in Syrian golden hamsters, upon challenge with SARS-CoV-2, the virus that causes COVID-19 in people. The data, published today in Nature Medicine, demonstrated that the Company’s investigational adenovirus serotype 26 (Ad26) vector-based vaccine elicited an immune response as demonstrated by “neutralizing antibodies” and prevented severe clinical disease – including weight loss, pneumonia and mortality – in Syrian golden hamsters upon challenge.This publication follows Johnson &...
Source: Johnson and Johnson - September 3, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news

Investigational COVID-19 vaccine candidate prevents severe clinical disease in animals
(Beth Israel Deaconess Medical Center) In new research published in Nature Medicine, Beth Israel Deaconess Medical Center immunologist Dan H. Barouch, MD, PhD, and colleagues demonstrated that the optimal vaccine elicited robust immune response in Syrian golden hamsters and prevented severe clinical disease -- including weight loss, pneumonia and death. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 3, 2020 Category: International Medicine & Public Health Source Type: news

In - Hospital Heart Failure Deaths Down With Routine Vaccinations
Patients with heart failure receiving flu, pneumonia vaccinations have lower in - hospital mortality (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 1, 2020 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Geriatrics, Gynecology, Infections, Internal Medicine, Nursing, Pharmacy, Pulmonology, Conference News, Source Type: news

In-Hospital Heart Failure Deaths Down With Routine Vaccinations
TUESDAY, Sept. 1, 2020 -- For patients with heart failure, influenza and pneumococcal vaccinations are associated with lower in-hospital mortality, according to a study presented at the European Society of Cardiology Congress 2020: The Digital... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 1, 2020 Category: Pharmaceuticals Source Type: news

Vaccine narrows racial disparities in pneumococcal disease
(Vanderbilt University Medical Center) In a major public health success, the introduction of pneumococcal conjugate vaccine PCV13, or Prevnar 13, in 2010 in the United States is associated with reduction in socioeconomic disparities and the near elimination of Black-white-based racial disparities for invasive pneumococcal disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 31, 2020 Category: International Medicine & Public Health Source Type: news

Flu, Pneumonia Vaccines Save Lives of Heart Failure Patients: Study
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - August 28, 2020 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Infections, Pulmonology, News, Source Type: news

Flu, Pneumonia Vaccines Save Lives of Heart Failure Patients: Study
FRIDAY, Aug. 28, 2020 -- Flu and pneumonia vaccines lead to fewer hospital deaths among heart failure patients, a new study finds. " Our study provides further impetus for annual immunizations in patients with heart failure. Despite advice to do so,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 28, 2020 Category: General Medicine Source Type: news

Flu, Pneumonia Vaccines Save Lives of Heart Failure Patients: Study
Title: Flu, Pneumonia Vaccines Save Lives of Heart Failure Patients: StudyCategory: Health NewsCreated: 8/28/2020 12:00:00 AMLast Editorial Review: 8/28/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - August 28, 2020 Category: Cardiology Source Type: news

Vaccines against respiratory infections linked with less heart failure deaths
(European Society of Cardiology) Influenza and pneumonia vaccinations are associated with fewer hospital deaths in patients with heart failure. That's the result of a study in nearly 3 million Americans released today at ESC Congress 2020. One out of five individuals will develop heart failure in their lifetime. An estimated 26 million people are affected worldwide. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 28, 2020 Category: International Medicine & Public Health Source Type: news

Exclusive: The Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Health - August 25, 2020 Category: Consumer Health News Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news

Exclusive: The Chinese Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Science - August 25, 2020 Category: Science Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news

Exclusive: The Chinese Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Health - August 25, 2020 Category: Consumer Health News Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news

How Convalescent Plasma Could Help Fight COVID-19
The last time most of us gave any thought to antibodies was probably in high school biology, but we’re getting a crash refresher course thanks to COVID-19. They are, after all, the key to our best defenses against SARS-CoV-2, the virus that’s caused the global pandemic. People who have been infected likely rely on antibodies to recover, and antibodies are what vaccines are designed to produce. Or at least that’s what infectious-disease and public-health experts assume for now. Because SARS-CoV-2 is such a new virus, even the world’s best authorities aren’t yet sure what it will take to build p...
Source: TIME: Health - August 24, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

SARS-CoV-2 infection protects against rechallenge in rhesus macaques
An understanding of protective immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for vaccine and public health strategies aimed at ending the global coronavirus disease 2019 (COVID-19) pandemic. A key unanswered question is whether infection with SARS-CoV-2 results in protective immunity against reexposure. We developed a rhesus macaque model of SARS-CoV-2 infection and observed that macaques had high viral loads in the upper and lower respiratory tract, humoral and cellular immune responses, and pathologic evidence of viral pneumonia. After the initial viral clearance, animals were recha...
Source: ScienceNOW - August 13, 2020 Category: Science Authors: Chandrashekar, A., Liu, J., Martinot, A. J., McMahan, K., Mercado, N. B., Peter, L., Tostanoski, L. H., Yu, J., Maliga, Z., Nekorchuk, M., Busman-Sahay, K., Terry, M., Wrijil, L. M., Ducat, S., Martinez, D. R., Atyeo, C., Fischinger, S., Burke, J. S., Sle Tags: Immunology, Microbiology r-articles Source Type: news

New experimental coronavirus vaccine boosted antibody levels in mice 90-fold
After researchers sprayed the novel coronavirus into the noses of the mice, those who were immunized didn't develop pneumonia or have high level of particles in their lungs, (Source: the Mail online | Health)
Source: the Mail online | Health - August 12, 2020 Category: Consumer Health News Source Type: news

Experimental COVID-19 vaccine prevents severe disease in mice
(Washington University School of Medicine) Researchers at Washington University School of Medicine in St. Louis have created a COVID-19 vaccine candidate from a replicating virus. This experimental vaccine has proven effective at preventing pneumonia in mice. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 11, 2020 Category: Infectious Diseases Source Type: news

RSV vaccination of pregnant women could prevent pneumonia in babies
(University of the Witwatersrand) Professor Shabir A. Madhi of the University of the Witwatersrand, Johannesburg, is the lead author of a study published in the prestigious New England Journal of Medicine on Thursday, 30 July 2020.The multinational, multicentre study reports on the first RSV vaccine to provide evidence that inmunisation of pregnant woman could protect young infants under six months old against severe RSV lower respiratory tract infection (LRTI). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 1, 2020 Category: International Medicine & Public Health Source Type: news

Flu, Pneumonia Vaccination Tied to Lower Dementia
Risk (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 29, 2020 Category: General Medicine Source Type: news

Flu, Pneumonia Vaccination Tied to Lower Dementia Risk Flu, Pneumonia Vaccination Tied to Lower Dementia Risk
Influenza and pneumococcal vaccination may lower risk for the development of Alzheimer's disease in older adults, two large observational studies suggest.Medscape Medical News (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - July 28, 2020 Category: Universities & Medical Training Tags: Psychiatry News Source Type: news

Pneumonia vaccine may cut Alzheimer's risk by up to 40%
A new study from Duke University found that receiving the pneumonia vaccine reduces the risk of developing Alzheimer's by 25% to 30% and up to 40% in those without genetic risk factors. (Source: the Mail online | Health)
Source: the Mail online | Health - July 28, 2020 Category: Consumer Health News Source Type: news

Could the Flu Shot Lower Your Risk for Alzheimer's?
Two new studies being presented Monday at this summer's virtual Alzheimer's Association International Conference found a lower incidence of Alzheimer's in people who got flu and pneumonia vaccines. (Source: WebMD Health)
Source: WebMD Health - July 27, 2020 Category: Consumer Health News Source Type: news

Flu and Pneumonia Vaccines Linked to Reduced Risk of Alzheimer's
The authors propose that the shots might keep the immune system primed to battle diseases that would otherwise contribute to cognitive decline. (Source: The Scientist)
Source: The Scientist - July 27, 2020 Category: Science Tags: News & Opinion Source Type: news

Could the Flu Shot Lower Your Risk for Alzheimer's?
MONDAY, July 27, 2020 -- Getting vaccinated to protect against pneumonia and flu may offer an unexpected benefit -- a lower risk of Alzheimer's disease, new research suggests. Two new studies being presented Monday at a virtual conference of the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 27, 2020 Category: General Medicine Source Type: news

Flu Shot And Pneumonia Vaccine Might Reduce Alzheimer's Risk, Research Shows
(Source: NPR Health and Science)
Source: NPR Health and Science - July 27, 2020 Category: Consumer Health News Authors: Jon Hamilton Source Type: news

Flu, pneumonia vaccinations tied to lower risk of Alzheimer's dementia
(Alzheimer's Association) Flu (influenza) and pneumonia vaccinations are associated with reduced risk of Alzheimer's disease, according to new research reported at the Alzheimer's Association International Conference ® (AAIC ® ) 2020. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 27, 2020 Category: International Medicine & Public Health Source Type: news

Morocco: Hospitals to Be Supplied With Influenza and Pneumococcal Vaccines This Autumn (Minister)
[MAP] Rabat -- Moroccan hospitals will be supplied with influenza and pneumococcal vaccines during the coming autumn, Health minister Khalid Ait Taleb announced on Saturday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 26, 2020 Category: African Health Source Type: news

Inside the Global Quest to Trace the Origins of COVID-19 —and Predict Where It Will Go Next
It wasn’t greed, or curiosity, that made Li Rusheng grab his shotgun and enter Shitou Cave. It was about survival. During Mao-era collectivization of the early 1970s, food was so scarce in the emerald valleys of southwestern China’s Yunnan province that farmers like Li could expect to eat meat only once a year–if they were lucky. So, craving protein, Li and his friends would sneak into the cave to hunt the creatures they could hear squeaking and fluttering inside: bats. Li would creep into the gloom and fire blindly at the vaulted ceiling, picking up any quarry that fell to the ground, while his companion...
Source: TIME: Health - July 23, 2020 Category: Consumer Health News Authors: Charlie Campbell/ Yuxi, Yunnan and Alice Park Tags: Uncategorized COVID-19 feature Magazine Source Type: news

India's 1st fully indigenously developed vaccine against pneumonia gets DCGI nod
The ministry said the vaccine will be used for active immunisatiuon against invasive disease and pneumonia caused by 'Streptococcus pneumonia' among infants. (Source: The Economic Times)
Source: The Economic Times - July 15, 2020 Category: Consumer Health News Source Type: news

Clinical guidance for healthcare professionals on maintaining immunisation programmes during COVID-19, NHS England (updated 29th June 2020)
The national immunisation programme is highly successful in reducing the incidence of serious and sometimes life-threatening diseases such as pneumococcal and meningococcal infections, whooping cough, diphtheria and measles. It remains important to maintain the best possible vaccine uptake to prevent a resurgence of these infections. This will also prevent increasing further the numbers of patients requiring health services, as well as outbreaks of vaccine-preventable diseases, and allow us to provide important protection to children and other vulnerable groups. Where possible, the routine immunisation programmes should be...
Source: Current Awareness Service for Health (CASH) - June 29, 2020 Category: Consumer Health News Source Type: news

Model May Help Predict Risk for Testing Positive for COVID - 19
Risk reduced with pneumococcal polysaccharide, flu vaccine; melatonin, paroxetine, or carvedilol use (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - June 25, 2020 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Critical Care, Emergency Medicine, Pathology, Pharmacy, Pulmonology, Journal, Source Type: news

UConn researchers overcome a vexing problem in vaccine research
(University of Connecticut) Researchers at UConn's Center of Excellence in Vaccine Research (CEVR) have made a breakthrough in vaccine development for a common and difficult to treat pneumonia-causing pathogen. Their research was recently published in the NPJ Vaccines (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 17, 2020 Category: Infectious Diseases Source Type: news

Subcutaneous Daratumumab Combination Resulted in Deep and Rapid Hematologic Responses and Improved Clinical Outcomes in the Treatment of Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
RARITAN, NJ, June 13, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the first randomized Phase 3 study investigating subcutaneous daratumumab[i] in the treatment of patients with newly diagnosed light chain (AL) amyloidosis, a rare and potentially fatal disease.[1],[2] The data demonstrated subcutaneous daratumumab in combination with cyclophosphamide, bortezomib, and dexamethasone (D-CyBorD) resulted in a higher hematologic complete response rate (CR), (53 percent vs. 18 percent [P
Source: Johnson and Johnson - June 15, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

‘Superforecasters’ Are Making Eerily Accurate Predictions About COVID-19. Our Leaders Could Learn From Their Approach
When Dr. Anthony Facui said in late May that there’s a “good chance” a COVID-19 vaccine will be ready by the end of this year, Steve Roth badly wanted to believe him. Roth, a 74-year-old New Yorker who endured fever, pneumonia and anxiety while fighting the virus, wants life to go back to normal as much as anyone. And he respects Fauci, the longtime head of the National Institute of Allergy and Infectious Diseases (NIAID), ”an awful lot,” he says. But he just doesn’t think Facui’s timeline is realistic. Instead, he’s putting his proverbial money on mid 2021. “Like every...
Source: TIME: Science - June 11, 2020 Category: Science Authors: Tara Law Tags: Uncategorized Source Type: news

‘Superforecasters’ Are Making Eerily Accurate Predictions About COVID-19. Our Leaders Could Learn From Their Approach
When Dr. Anthony Fauci said in late May that there’s a “good chance” a COVID-19 vaccine will be ready by the end of this year, Steve Roth badly wanted to believe him. Roth, a 74-year-old New Yorker who endured fever, pneumonia and anxiety while fighting the virus, wants life to go back to normal as much as anyone. And he respects Fauci, the longtime head of the National Institute of Allergy and Infectious Diseases (NIAID), ”an awful lot,” he says. But he just doesn’t think Fauci’s timeline is realistic. Instead, he’s putting his proverbial money on mid 2021. “Like every...
Source: TIME: Health - June 11, 2020 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized Source Type: news

Only About Half of Americans Would Get a COVID-19 Vaccine, Poll Finds
Only about half of Americans say they would get a COVID-19 vaccine if the scientists working furiously to create one succeed, according to a new poll from The Associated Press-NORC Center for Public Affairs Research. That’s surprisingly low considering the effort going into the global race for a vaccine against the coronavirus that has sparked a pandemic since first emerging from China late last year. But more people might eventually roll up their sleeves: The poll, released Wednesday, found 31% simply weren’t sure if they’d get vaccinated. Another 1 in 5 said they’d refuse. Health experts already w...
Source: TIME: Health - May 27, 2020 Category: Consumer Health News Authors: Lauran Neergaard and Hannah Fingerhut / AP Tags: Uncategorized COVID-19 News Desk wire Source Type: news

Only Half Of Americans Would Get A Coronavirus Vaccine, Poll Shows
(AP) – Only about half of Americans say they would get a COVID-19 vaccine if the scientists working furiously to create one succeed, according to a new poll from The Associated Press-NORC Center for Public Affairs Research. That’s surprisingly low considering the effort going into the global race for a vaccine against the coronavirus that has sparked a pandemic since first emerging from China late last year. But more people might eventually roll up their sleeves: The poll, released Wednesday, found 31% simply weren’t sure if they’d get vaccinated. Another 1 in 5 said they’d refuse. Moderna the...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 27, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Covid-19 Boston, MA Health Healthcare Status Syndicated CBSN Boston Syndicated Local Coronavirus Source Type: news

Will Emerging Contact Tracing Solutions Be Put to Work?
Resolve to Save Lives, an initiative launched by global health organization Vital Strategies, released a playbook that describes four essential actions governments need to take to reopen society quickly and safely in the midst of the COVID-19 pandemic: Test widely—> Isolate infected people—> Find people who have been in contact with infected people—> Ask those people to quarantine for 14 days. Step three—contact tracing—is crucial for controlling spread of the novel coronavirus and for understanding how it spreads. While tech...
Source: MDDI - May 26, 2020 Category: Medical Devices Authors: Heather R. Johnson Tags: Digital Health Source Type: news

U.K. COVID-19 Study Aims to Immunize More Than 10,000 with Experimental Vaccine
(London) — British researchers testing an experimental vaccine against the new coronavirus are moving into advanced studies and aim to immunize more than 10,000 people to determine if the shot works. Last month, scientists at Oxford University began vaccinating more than 1,000 volunteers in a preliminary study designed to test the shot’s safety. Those results aren’t in yet but on Friday, the scientists announced they’re expanding to 10,260 people across Britain, including older people and children. If all goes smoothly, “it’s possible as early as the autumn or toward the end of the year,...
Source: TIME: Health - May 22, 2020 Category: Consumer Health News Authors: aria Cheng and Lauran Neergaard / AP Tags: Uncategorized COVID-19 News Desk wire Source Type: news

Monkey trial of Oxford vaccine shows encouraging results
When they exposed the animals to coronavirus, the monkeys that weren't vaccinated developed pneumonia, a sign of COVID-19 — but those that weren't vaccinated did not. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 16, 2020 Category: Consumer Health News Source Type: news

Investigational ChAdOx1 nCoV-19 vaccine protects monkeys against COVID-19 pneumonia
Study provided data for clinical testing to commence. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - May 15, 2020 Category: American Health Source Type: news

Leave Clothes Out In The Sun? Do Flu Shots Protect? Dr. Mallika Marshall Answers Your Coronavirus Questions
BOSTON (CBS) — As Massachusetts continues to fight the coronavirus pandemic, the public has plenty of questions. Dr. Mallika Marshall answered some of those sent to her email (drmallika@cbs.com) and Facebook and Twitter accounts. I want know why all of these surgeries have been canceled. Mine was canceled and I’m in a lot of pain. – Trish, Canada Not just in Canada. Elective and nonemergency surgeries have been postponed throughout the U.S. in an effort to protect patients, healthcare workers, and free up hospital beds. Hospitals are anxious to resume elective surgeries, but the a...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 15, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Syndicated Local Coronavirus Dr. Mallika Marshall Source Type: news

How Safe Is The Meat Supply Chain? Dr. Mallika Marshall Answers Your Coronavirus Questions
BOSTON (CBS) – As the number of coronavirus cases continues to grow, we are receiving a number of questions from the public. Dr. Mallika Marshall answered some of the questions sent to WBZ-TV’s Facebook, Instagram and Twitter accounts. What does ‘non-conclusive’ mean regarding COVID-19 test results? – Karen, Facebook An inconclusive test means it can’t confirm whether a patient is positive or negative for the coronavirus. The current test looks for the presence of two genes associated with the virus. If both genes are found, the test is positive. If neither is found, it’s nega...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 29, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Syndicated Local Coronavirus Dr. Mallika Marshall Source Type: news